Journal of Molecular and Cellular Cardiology
Volume 50, Issue 2 , Pages 312-319 , February 2011

Adult stem cells for cardiac tissue engineering

  • Eliana C. Martinez

      Affiliations

    • Department of Surgery, National University of Singapore, Singapore, Singapore
    • ,
  • Theo Kofidis

      Affiliations

    • Department of Surgery, National University of Singapore, Singapore, Singapore
    • Department of Cardiac, Thoracic and Vascular Surgery, National University Hospital, Singapore, Singapore
    • Corresponding Author InformationCorresponding author. Department of Surgery, National University of Singapore, 5 Lower Kent Ridge Road, Level 2, Singapore 119074, Singapore. Tel.: +65 6772 2065; fax: +65 6775 8538.

Received 31 May 2010 ,Revised 15 July 2010 ,Accepted 6 August 2010.

References 

  1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. Feb 23 2010;121(7):948–954
  2. Koerner MM, Durand JB, Lafuente JA, Noon GP, Torre-Amione G. Cardiac transplantation: the final therapeutic option for the treatment of heart failure. Curr Opin Cardiol. May 2000;15(3):178–182
  3. Zimmermann WH, Eschenhagen T. Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc Med. May 2007;17(4):134–140
  4. Kofidis T, de Bruin JL, Hoyt G, Ho Y, Tanaka M, Yamane T, et al. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant. Jun 2005;24(6):737–744
  5. Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ Res. Apr 28 2006;98(8):1002–1013
  6. Kehat I, Gepstein L. Human embryonic stem cells for myocardial regeneration. Heart Fail Rev. Jul 2003;8(3):229–236
  7. Martinez EC, Kofidis T. Myocardial tissue engineering: the quest for the ideal myocardial substitute. Expert Rev Cardiovasc Ther. Aug 2009;7(8):921–928
  8. Chachques JC. Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure?. Eur J Cardiothorac Surg. Feb 2009;35(2):201–203
  9. Bursac N. Cardiac tissue engineering using stem cells. IEEE Eng Med Biol Mag Mar–Apr 2009; 286(2): 80, 2, 4–6, 8–9.
  10. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci. Jun 2001;938:221–229(discussion 9–30)
  11. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. Apr 5 2001;410(6829):701–705
  12. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. Jan 1 2002;105(1):93–98
  13. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct. Aug 2008;26(6):664–675
  14. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. Sep 19 2003;114(6):763–776
  15. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. Oct 29 2004;95(9):911–921
  16. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. Aug 28 2001;98(18):10344–10349
  17. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, Majesky MW, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. Jun 2001;107(11):1395–1402
  18. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. Jul 10–16 2004;364(9429):141–148
  19. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. Oct 19 2004;44(8):1690–1699
  20. Dobert N, Britten M, Assmus B, Berner U, Menzel C, Lehmann R, et al. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT. Eur J Nucl Med Mol Imaging. Aug 2004;31(8):1146–1151
  21. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. Apr 8 2004;428(6983):668–673
  22. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. Apr 8 2004;428(6983):664–668
  23. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, Lippolt P, et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J. Dec 2009;30(24):2978–2984
  24. Schaefer A, Zwadlo C, Fuchs M, Meyer GP, Lippolt P, Wollert KC, et al. Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial—an echocardiographic study.. Eur J Echocardiogr. Mar 2010;11(2):165–171
  25. Berry MF, Engler AJ, Woo YJ, Pirolli TJ, Bish LT, Jayasankar V, et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. Jun 2006;290(6):H2196–H2203
  26. Grinnemo KH, Mansson-Broberg A, Leblanc K, Corbascio M, Wardell E, Siddiqui AJ, et al. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med. 2006;38(2):144–153
  27. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. Mar 1999;103(5):697–705
  28. Fukuda K. Regeneration of cardiomyocytes from bone marrow: use of mesenchymal stem cell for cardiovascular tissue engineering. Cytotechnology. Mar 2003;41(2–3):165–175
  29. Bartunek J, Croissant JD, Wijns W, Gofflot S, de Lavareille A, Vanderheyden M, et al. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol. Feb 2007;292(2):H1095–H1104
  30. Genovese JA, Spadaccio C, Chachques E, Schussler O, Carpentier A, Chachques JC, et al. Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Front Biosci. 2009;14:2996–3002
  31. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. Mar 19 2004;94(5):678–685
  32. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. Nov 2007;213(2):341–347
  33. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation. Aug 23 2005;112(8):1128–1135
  34. Muller-Ehmsen J, Whittaker P, Kloner RA, Dow JS, Sakoda T, Long TI, et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. Feb 2002;34(2):107–116
  35. Reinecke H, Murry CE. Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J Mol Cell Cardiol. Mar 2002;34(3):251–253
  36. Wang H, Zhou J, Liu Z, Wang C. Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med. Feb 27 2010;14(5):1044–1055
  37. Teng CJ, Luo J, Chiu RC, Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg. Sep 2006;132(3):628–632
  38. Zhang H, Song P, Tang Y, Zhang XL, Zhao SH, Wei YJ, et al. Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. J Thorac Cardiovasc Surg. Nov 2007;134(5):1234–1240
  39. Dai W, Hale SL, Kay GL, Jyrala AJ, Kloner RA. Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med. May 2009;4(3):387–395
  40. Leor J, Amsalem Y, Cohen S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther. Feb 2005;105(2):151–163
  41. Coutu DL, Yousefi AM, Galipeau J. Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy. J Cell Biochem. Oct 15 2009;108(3):537–546
  42. Leor J, Cohen S. Myocardial tissue engineering: creating a muscle patch for a wounded heart. Ann N Y Acad Sci. May 2004;1015:312–319
  43. Barandon L, Couffinhal T, Dufourcq P, Alzieu P, Daret D, Deville C, et al. Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model. Ann Thorac Surg. Oct 2004;78(4):1409–1417
  44. Wei HJ, Chen SC, Chang Y, Hwang SM, Lin WW, Lai PH, et al. Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model. Biomaterials. Nov 2006;27(31):5409–5419
  45. Chen CH, Wei HJ, Lin WW, Chiu I, Hwang SM, Wang CC, et al. Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. Cardiovasc Res. Oct 1 2008;80(1):88–95
  46. Sekiya S, Shimizu T, Yamato M, Kikuchi A, Okano T. Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential. Biochem Biophys Res Commun. Mar 10 2006;341(2):573–582
  47. Wei HJ, Chen CH, Lee WY, Chiu I, Hwang SM, Lin WW, et al. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials. Sep 2008;29(26):3547–3556
  48. Tan MY, Zhi W, Wei RQ, Huang YC, Zhou KP, Tan B, et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials. Mar 2 2009;19:3234–3240
  49. Xiang Z, Liao R, Kelly MS, Spector M. Collagen-GAG scaffolds grafted onto myocardial infarcts in a rat model: a delivery vehicle for mesenchymal stem cells. Tissue Eng. Sep 2006;12(9):2467–2478
  50. Simpson D, Liu H, Fan TH, Nerem R, Dudley SC. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells. Sep 2007;25(9):2350–2357
  51. Yang MC, Wang SS, Chou NK, Chi NH, Huang YY, Chang YL, et al. The cardiomyogenic differentiation of rat mesenchymal stem cells on silk fibroin-polysaccharide cardiac patches in vitro. Biomaterials. Aug 2009;30(22):3757–3765
  52. Fukuhara S, Tomita S, Nakatani T, Fujisato T, Ohtsu Y, Ishida M, et al. Bone marrow cell-seeded biodegradable polymeric scaffold enhances angiogenesis and improves function of the infarcted heart. Circ J. Jul 2005;69(7):850–857
  53. Piao H, Kwon JS, Piao S, Sohn JH, Lee YS, Bae JW, et al. Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials. Feb 2007;28(4):641–649
  54. Jin J, Jeong SI, Shin YM, Lim KS, Shin H, Lee YM, et al. Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail. Feb 2009;11(2):147–153
  55. Chachques JC, Trainini JC, Lago N, Cortes-Morichetti M, Schussler O, Carpentier A. Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg. Mar 2008;85(3):901–908
  56. Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK, Piao H, et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials. Jan 2005;26(3):319–326
  57. Wang CC, Chen CH, Lin WW, Hwang SM, Hsieh PC, Lai PH, et al. Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. Cardiovasc Res. Feb 1 2008;77(3):515–524
  58. Martens TP, Godier AF, Parks JJ, Wan LQ, Koeckert MS, Eng GM, et al. Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant. 2009;18(3):297–304
  59. Zhu Y, Liu T, Song K, Jiang B, Ma X, Cui Z. Collagen-chitosan polymer as a scaffold for the proliferation of human adipose tissue-derived stem cells. J Mater Sci Mater Med. Mar 2009;20(3):799–808
  60. Planat-Benard V, Menard C, Andre M, Puceat M, Perez A, Garcia-Verdugo JM, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. Feb 6 2004;94(2):223–229
  61. Choi YS, Matsuda K, Dusting GJ, Morrison WA, Dilley RJ. Engineering cardiac tissue in vivo from human adipose-derived stem cells. Biomaterials. Mar 2010;31(8):2236–2242
  62. Schenke-Layland K, Strem BM, Jordan MC, Deemedio MT, Hedrick MH, Roos KP, et al. Adipose tissue-derived cells improve cardiac function following myocardial infarction. J Surg Res. May 15 2009;153(2):217–223
  63. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. Apr 2006;12(4):459–465
  64. Mouquet F, Pfister O, Jain M, Oikonomopoulos A, Ngoy S, Summer R, et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res. Nov 25 2005;97(11):1090–1092
  65. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, et al. Human cardiac stem cells. Proc Natl Acad Sci U S A. Aug 28 2007;104(35):14068–14073
  66. Bartosh TJ, Wang Z, Rosales AA, Dimitrijevich SD, Roque RS. 3D-model of adult cardiac stem cells promotes cardiac differentiation and resistance to oxidative stress. J Cell Biochem. Oct 1 2008;105(2):612–623
  67. Nakanishi C, Yamagishi M, Yamahara K, Hagino I, Mori H, Sawa Y, et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun. Sep 12 2008;374(1):11–16
  68. Zakharova L, Mastroeni D, Mutlu N, Molina M, Goldman S, Diethrich E, et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc Res. Jul 1 2010;87(1):40–49
  69. Li Z, Lee A, Huang M, Chun H, Chung J, Chu P, et al. Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol. Apr 7 2009;53(14):1229–1240
  70. Xin Y, Wang YM, Zhang H, Li J, Wang W, Wei YJ, et al. Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction. Artif Organs. Apr 20 2010;34(3):215–222
  71. Fazel S, Cimini M, Chen L, Li S, Angoulvant D, Fedak P, et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. Jul 2006;116(7):1865–1877
  72. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation. Jul 12 2005;112(2):214–223
  73. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. Feb 15 2003;75(3):389–397
  74. Poh KK, Sperry E, Young RG, Freyman T, Barringhaus KG, Thompson CA. Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, “off-the-shelf”, cellular cardiomyoplasty strategy. Int J Cardiol. May 2 2007;117(3):360–364
  75. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood. Sep 15 2006;108(6):2114–2120
  76. Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, et al. Transplantation. Mar 15 2003;75(5):679–685
  77. Kunter U, Rong S, Boor P, Eitner F, Muller-Newen G, Djuric Z, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol. Jun 2007;18(6):1754–1764
  78. Wang Y, Huso DL, Harrington J, Kellner J, Jeong DK, Turney J, et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy. 2005;7(6):509–519
  79. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, Jensen T, et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene. Jun 24 2004;23(29):5095–5098
  80. Smith RR, Barile L, Messina E, Marban E. Stem cells in the heart: what's the buzz all about? Part 2: arrhythmic risks and clinical studies. Heart Rhythm. Jun 2008;5(6):880–887
  81. Katritsis DG, Sotiropoulou P, Giazitzoglou E, Karvouni E, Papamichail M. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace. Mar 2007;9(3):167–171
  82. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. Apr 2005;11(4):367–368
  83. Lionetti V, Bianchi G, Recchia FA, Ventura C. Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. Heart Fail Rev. Apr 3 2010;[Electronic publication ahead of print] PMID: 20364318
  84. Eschenhagen T, Didie M, Heubach J, Ravens U, Zimmermann WH. Cardiac tissue engineering. Transpl Immunol. May 2002;9(2–4):315–321

PII: S0022-2828(10)00296-8

doi: 10.1016/j.yjmcc.2010.08.009

Journal of Molecular and Cellular Cardiology
Volume 50, Issue 2 , Pages 312-319 , February 2011

Article Tools

* Image Usage & Resolution